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-Wave Alternans and
uman Ventricular Arrhythmias
hat Is the Link?*
anjiv M. Narayan, MB, MD, FACC
a Jolla and San Diego, California
udden cardiac arrest (SCA) from ventricular arrhyth-
ias affects over 400,000 individuals/year in the U.S.
lone and has a dismal survival rate (1). Although
educed left ventricular systolic function (i.e., left ven-
ricular ejection fraction) (2) and symptomatic heart
ailure (i.e., congestive heart failure) (3) are the major
redictors of risk for SCA, they are more sensitive than
hey are specific. Thus, their primacy in guidelines for
mplantable cardioverter-defibrillators (ICDs) might lead
o potentially unnecessary implantations (1). This moti-
ates the identification of markers for the pathophysiol-
gy of ventricular arrhythmias that can improve indices
or ICD insertion.
See page 338
Several candidates exist. Inducing sustained ventricular
rrhythmias at electrophysiologic study (EPS) was histori-
ally the gold standard but has become tarnished of late.
ertainly, SCA is more frequent in ischemic cardiomyop-
thy patients with positive EPS, yet those with negative
PS still have a substantial arrhythmic risk (4,5). The
recise reasons why the initiation of ventricular arrhythmias
t EPS suboptimally predicts outcome or why EPS is less
seful in non-ischemic cardiomyopathy are unclear (1).
herefore, attention has turned to indices of slow con-
uction and exaggerated dispersion of repolarization that
re central to reentrant arrhythmogenesis. Evidence for
lowed conduction after myocardial infarction, assessed
ndirectly by the signal averaged electrocardiogram
ECG) (6), successfully predicted SCA in the MUSTT
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ureau for Guidant/Boston Scientific Corporation.Multicenter Unsustained Tachycardia Trial) (7). Ele-
ated sympathetic nervous activity increases the disper-
ion of repolarization and—when detected by cardiac
uclear imaging (8), reduced heart rate variability (9), or
eart rate turbulence (10)—predicts events after myocar-
ial infarction. Ventricular stretch slows conduction and
xaggerates repolarization dispersion (11), and accord-
ngly, elevated serum levels of B-type natriuretic peptide
redict SCA in cardiomyopathy patients (12).
T-wave alternans (TWA) is a promising ECG risk factor
hat indicates alternate-beat changes in T-wave shape or
mplitude and reflects repolarization dispersion (13). In a
ecade of contemporary clinical use (14), TWA has shown
negative predictive accuracy for SCA above 90% in a
umulative population of thousands of cardiomyopathy
atients, both ischemic and non-ischemic (15,16). Accord-
ngly, Markov models suggest that TWA should improve
he economics of ICD insertion (17).
So, then, is TWA a fully developed risk stratifier? To be
levated in status above that of a mere epiphenomenon, an
deal risk stratifier must be plausible, predictive, and patho-
hysiological. Certainly, TWA meets the first 2 criteria.
owever, a divide exists between animal studies—where
WA has been linked with repolarization dispersion and
rrhythmias, albeit under extreme conditions of acute isch-
mia, hypothermia, very rapid pacing, or drug pro-
rrhythmia (13,18–20)—and the dearth of clinical studies
inking TWA with arrhythmogenesis under the conditions
hat might precede SCA.
In this issue of the Journal, Selvaraj et al. (21) provide
mportant data to bridge this divide. In a small population
f patients with ischemic and nonischemic cardiomyop-
thy, the authors compared ECG TWA with intracardiac
epolarization alternans (RPA), using multipole catheters
n the right ventricular endocardium and, via the anterior
nterventricular vein, the left ventricular epicardium. The
patial and temporal concordances that they describe
trengthen the pathophysiologic basis of TWA and
uggest ways in which it could be further refined as a
linical tool.
Selvaraj et al. (21) report that RPA was seen at more
ntracardiac sites in patients with than without TWA,
onsistent with the step-down in alternans magnitude seen
rom the heart to the T-wave in isolated rabbit (22) and
uinea pig (20) hearts. This poses the question of what RPA
agnitude contributes to lethal ventricular arrhythmias.
ddressing this question requires studies of RPA in control
ubjects without left ventricular dysfunction, which might
elp explain “false-positive” tests that diminish the positive
redictive value of TWA for SCA (13). It also requires
omparison against arrhythmic outcome that was not re-
orted by Selvaraj et al. (21) but could be used to define
eceiver-operating characteristics of RPA for SCA in a
arger cohort.
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Editorial Comment January 23, 2007:347–9Selvaraj et al. (21) also report that RPA was spatially
on-uniform and more prevalent in left ventricular epicar-
ial than right ventricular endocardial sites. Normal rabbit
earts also show maximal RPA in the left ventricular free
all (22). Although sites of maximal RPA might vary
ynamically (20), one might hypothesize that RPA in
schemic cardiomyopathy is maximal near scar and that
atient-tailored spatial analysis could optimize the utility of
WA. Indeed, the TWA vector was recently shown to
eflect echocardiographic scar in patients with ischemic
ardiomyopathy (23), and cardiomyopathy patients with
ore extensive TWA (i.e., in more ECG leads) have more
rrhythmic events (24). Selvaraj et al. (21) also suggest a
ransmural gradient in RPA, yet their recordings did not span
he same myocardial region, so this needs further validation.
Notably, spatial non-uniformity in RPA suggests a mech-
nism by which unfortunately timed beats might encounter
egional block to initiate re-entry. In animals, spatially
on-uniform RPA after premature beats, rapid pacing (20),
r acute ischemia (18) might lead to discordant alternans,
here juxtaposed myocardial regions alternate with opposite
hase, leading to unidirectional block, re-entry, and ventric-
lar fibrillation (18,20). The “discordance” noted in patients
y Selvaraj et al. (21) is likely different, not just because no
atient imminently developed ventricular arrhythmias but
lso because of the integrative effects of unipolar recordings
nd their T waves. First, by averaging a wide field, unipolar
ecordings might not reflect homogeneous region whose
ells all alternate with 1 phase so that the line of block
eeded to initiate reentry might not form (20). Second,
nipolar “T waves” integrate many action potentials and
ave arbitrary polarity, unlike action potentials. Discordant
PA could thus reflect differences in baseline T-wave
olarity between sites rather than discordant cellular
lternans. Nevertheless, it is important to study arrhyth-
ic outcome in patients with discordant RPA or an ECG
WA surrogate. We recently reported that premature
eats, which produced discordant RPA in some patients
eported by Selvaraj et al. (21), might reverse the phase of
CG TWA in cardiomyopathy patients. Such patients
ent on to suffer a markedly worse outcome than those
ith TWA but without phase reversal (25). Studies are
eeded to verify whether TWA phase reversal or another
ndex reflects a particularly pro-arrhythmic intracardiac
ispersion of repolarization.
Selvaraj et al. (21) should be commended on their novel
nd important study that begins to link TWA with disper-
ion of ventricular repolarization and arrhythmogenesis in
umans. Future work should relate RPA to regional struc-
ural abnormalities and to the rate-dynamics of action
otential duration (26). In particular, it is important to
efine the routes leading to spatial non-uniformity and their
elation to arrhythmic outcome. Such studies might help
efine TWA indices of dynamic arrhythmic susceptibility
nd, in parallel, shed valuable insights into human ventric-
lar arrhythmogenesis.eprint requests and correspondence: Dr. Sanjiv M. Narayan,
lectrophysiology Service, VA San Diego, University of California
an Diego, Box 111A, 3350 La Jolla Village Drive, San Diego,
alifornia 92161. E-mail: snarayan@ucsd.edu.
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